Jose Manasanch
Teia, CT 08329, Spain
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Efficacy and Tolerability of 6-Month Treatment with Tamsulosin Plus the Hexanic Extract of Serenoa repens versus Tamsulosin Plus 5-Alpha-Reductase Inhibitors for Moderate-to-Severe LUTS-BPH Patients: Results of a Paired Matched Clinical Study.
Journal: Journal of clinical medicine
Published: May 05, 2022
Efficacy and Safety of the Hexanic Extract of Serenoa repens vs. Watchful Waiting in Men with Moderate to Severe LUTS-BPH: Results of a Paired Matched Clinical Study.
Journal: Journal of clinical medicine
Published: December 22, 2021
Efficacy and tolerability of the hexanic extract of Serenoa repens compared to tamsulosin in moderate-severe LUTS-BPH patients.
Journal: Scientific reports
Published: May 27, 2021
Clinical Benefit of Tamsulosin and the Hexanic Extract of Serenoa Repens, in Combination or as Monotherapy, in Patients with Moderate/Severe LUTS-BPH: A Subset Analysis of the QUALIPROST Study.
Journal: Journal of clinical medicine
Published: July 30, 2020
Efficacy and safety of ossein-hydroxyapatite complex versus calcium carbonate to prevent bone loss.
Journal: Climacteric : the journal of the International Menopause Society
Published: November 22, 2019
Quality of life in patients with lower urinary tract symptoms associated with BPH: change over time in real-life practice according to treatment--the QUALIPROST study.
Journal: International urology and nephrology
Published: October 19, 2015
Phytotherapy in urology. Current scientific evidence of its application in benign prostatic hyperplasia and prostate adenocarcinoma.
Journal: Actas urologicas espanolas
Published: May 27, 2013
Tolerability of different oral iron supplements: a systematic review.
Journal: Current medical research and opinion
Published: December 21, 2012
Comparison of the effects of ossein-hydroxyapatite complex and calcium carbonate on bone metabolism in women with senile osteoporosis: a randomized, open-label, parallel-group, controlled, prospective study.
Journal: Clinical drug investigation
Published: November 01, 2011
Showing 1-9 of 9
Last Updated: 09/26/2026